Modeling Clinical Endpoints as a Function of Time of Switch to Second‐Line ART with Incomplete Data on Switching Times
From MaRDI portal
Publication:2861966
DOI10.1111/BIOM.12064zbMath1429.62551OpenAlexW4298677188WikidataQ30655744 ScholiaQ30655744MaRDI QIDQ2861966
Brent A. Johnson, Roy M. Gulick, Joseph J. Jun. Eron, Heather Ribaudo
Publication date: 13 November 2013
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.17615/p0k8-y378
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Estimation in survival analysis and censored data (62N02)
Related Items (1)
Cites Work
- Unnamed Item
- Treatment-competing events in dynamic regimes
- Estimation of Survival Distributions of Treatment Policies in Two-Stage Randomization Designs in Clinical Trials
- Estimating Mean Response as a Function of Treatment Duration in an Observational Study, Where Duration May Be Informatively Censored
- Semiparametric inference in observational duration-response studies, with duration possibly right-censored
- Marginal Mean Models for Dynamic Regimes
- Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095
This page was built for publication: Modeling Clinical Endpoints as a Function of Time of Switch to Second‐Line ART with Incomplete Data on Switching Times